The progress in C9orf72 research: ALS/FTD pathogenesis, functions and structure

Small GTPases. 2022 Jan;13(1):56-76. doi: 10.1080/21541248.2021.1892443. Epub 2021 Mar 5.

Abstract

The hexanucleotide repeat (GGGGCC) expansion in C9orf72 is accounted for a large proportion of the genetic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The hypotheses of how the massive G4C2 repeats in C9orf72 destroy the neurons and lead to ALS/FTD are raised and improving. As a multirole player, C9orf72 exerts critical roles in many cellular processes, including autophagy, membrane trafficking, immune response, and so on. Notably, the partners of C9orf72, through which C9orf72 participates in the cell activities, have been identified. Notably, the structures of the C9orf72-SMCR8-WDR41 complex shed light on its activity as GTPase activating proteins (GAP). In this manuscript, we reviewed the latest research progress in the C9orf72-mediated ALS/FTD, the physiological functions of C9orf72, and the putative function models of C9orf72/C9orf72-containing complex.

Keywords: C9orf72; DENN domain; GAP; GEF; SMCR8; WDR41; autophagy; lysosome; mTOR; membrane trafficking; neurodegenerative.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Amyotrophic Lateral Sclerosis* / metabolism
  • Amyotrophic Lateral Sclerosis* / pathology
  • Autophagy / genetics
  • C9orf72 Protein / genetics
  • C9orf72 Protein / metabolism
  • Frontotemporal Dementia* / genetics
  • Frontotemporal Dementia* / metabolism
  • Frontotemporal Dementia* / pathology
  • GTPase-Activating Proteins
  • Humans

Substances

  • C9orf72 Protein
  • GTPase-Activating Proteins
  • C9orf72 protein, human

Grants and funding

This work was supported by the National Key R&D Program of China [2017YFA0506300]; NSFC [31770820]; NSFC [32071214]; National Key R&D Program of China [2018YFC1004601].